Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma
Expert Review of Anticancer Therapy, 08/17/09
Meyers PA - Each year in US and Europe approximately 1000 new patients are diagnosed with osteosarcoma. Current treatment for osteosarcoma utilizes multiagent chemotherapy and surgical resection of all clinically detectable disease, that can achieve 60–70% event-free survival (EFS) for pts with localized disease and approximately 20% EFS for pts who present with metastasis.
Related Articles
Caffeine-potentiated chemotherapy for metastatic osteosarcoma
Journal of Orthopaedic Science, 10/06/09
Relevance Score: 67%
Age as a prognostic factor for patients with osteosarcoma: an analysis of 438 patients
Journal of Cancer Research & Clinical Oncology, 10/01/09
Relevance Score: 65%
Approved Lymphoma Drug Shows Promise In Early Tests Against Bone Cancer
ScienceDaily, 11/10/09
Relevance Score: 64%
A phase 2 clinical trial of nab-paclitaxel in previously treated and chemotherapy-naive patients with metastatic melanoma
Cancer, 11/09/09
Relevance Score: 46%
Selective internal radiation therapy for liver metastases from colorectal cancer
Cochrane Reviews, 10/09/09
Relevance Score: 46%
Today in Bone/Cartilage...keeping you current
Receive free subspecialty "5-minute updates" via email
Interventional radiology procedures in the treatment of bone metastasis
Bulletin du Cancer, 12/01/09
The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES)
Cancer, 11/25/09
Therapeutic Potential of Adult Bone Marrow-Derived Mesenchymal Stem Cells in Prostate Cancer Bone Metastasis
Clinical Cancer Research, 11/23/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Melphalan 200 mg/m2 versus Melphalan 100 mg/m2 in newly diagnosed myeloma patients: A prospective, multi-center phase III study
Blood, 12/02/09
ETAR antagonist ZD4054 exhibits additive effects with aromatase inhibitors and fulvestrant in breast cancer therapy, and improves in vivo efficacy of anastrozole
Breast Cancer Research and Treatment, 12/02/09
A novel synthetic iminoquinone, BA-TPQ, as an anti-breast cancer agent: in vitro and in vivo activity and mechanisms of action
Breast Cancer Research and Treatment, 12/02/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


